Familial retinoblastoma in developing countries

Pediatric Blood and Cancer

Volumn 53, Issue 3, 2009, Pages 338-342

  Chantada, Guillermo L ^a   Dunkel, Ira J ^b   Qaddoumi, Ibrahim ^c   Antoneli, Celia B G ^d   Totah, Alegria ^e   Canturk, Serife ^f   Nawaiseh, Ibrahim ^c   Fandiño, Adriana ^a   Pífano, Imelda ^e   Peksayar, Gonul ^f   Ribeiro, Karina Braga ^g   Abramson, David H ^b  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c KING HUSSEIN CANCER CENTER   (Jordan)

^d A C CAMARGO CANCER CENTER   (Brazil)

^e UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^f ISTANBUL UNIVERSITY   (Turkey)

^g FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

Author keywords

Developing countries; Diagnosis; Familial retinoblastoma

Indexed keywords

ARGENTINA; ARTICLE; BRAZIL; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RECURRENCE; CANCER RELAPSE; CANCER SCREENING; CANCER SURVIVAL; CHILD; DEVELOPING COUNTRY; ENUCLEATION; EXTERNAL BEAM RADIOTHERAPY; EYE DISEASE; FAMILIAL DISEASE; HUMAN; INFANT; JORDAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; METASTASIS; MORBIDITY; MORTALITY; OPTIC NERVE LESION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINOBLASTOMA; RETROSPECTIVE STUDY; RISK; RISK FACTOR; SURVIVAL RATE; TURKEY (REPUBLIC); UNITED STATES; VENEZUELA;

CHILD, PRESCHOOL; COHORT STUDIES; DEVELOPING COUNTRIES; HUMANS; INFANT; INFANT, NEWBORN; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES;

EID: 67651202876     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21970     Document Type: Article

References (23)

1. Gurney JG, Ross JA, Wall DA, et al. Infant cancer in the U.S.: Histology-specific incidence and trends, 1973-1992. J Pediatr Hematol Oncol 1997;19:428-432.
2. Imhof SM, Moll AC, Schouten-van Meeteren AY. Stage of presentation and visual outcome of patients screened for familial retinoblastoma: Nationwide registration in the Netherlands. Br J Ophthalmol 2006;90:875-878.
3. Kenney LB, Miller BA, Ries LA, et al. Increased incidence of cancer in infants in the U.S.: 1980-1990. Cancer 1998;82:1396-1400.
4. Monteiro AN, Waizbort R. The accidental cancer geneticist: hilario de gouvea and hereditary retinoblastoma. Cancer Biol Ther 2007; 6:811-813.
5. Abramson DH, Mendelsohn ME, Servodidio CA, et al. Familial retinoblastoma: Where and when? Acta Ophthalmol Scand 1998; 76:334-338.
6. Wallach M, Balmer A, Munier F, et al. Shorter time to diagnosis and improved stage at presentation in Swiss patients with retinoblastoma treated from 1963-2004. Pediatrics 2006;118: e1493-e1498.
7. Chantada G, Fandino A, Manzitti J, et al. Late diagnosis of retinoblastoma in a developing country. Arch Dis Child 1999; 80:171-174. (Pubitemid 29119732)
8. Bowman RJ, Mafwiri M, Luthert P, et al. Outcome of retinoblastoma in east Africa. Pediatr Blood Cancer 2008;50:160-162.
9. Antoneli CB, Steinhorst F, de Cassia Braga Ribeiro K, et al. Extraocular retinoblastoma: A 13-year experience. Cancer 2003; 98:1292-1298.
10. Chantada G, Fandino A, Davila MT, et al. Results of a prospective study for the treatment of retinoblastoma. Cancer 2004;100:834-842. (Pubitemid 38176864)
11. Ozkan A, Pazarli H, Celkan T, et al. Retinoblastoma in Turkey: Survival and clinical characteristics 1981-2004. Pediatr Int 2006;48:369-373.
12. Qaddoumi I, Nawaiseh I, Mehyar M, et al. Team management, twinning, and telemedicine in retinoblastoma: A 3-tier approach implemented in the first eye salvage program in Jordan. Pediatr Blood Cancer 2008;51:241-244. (Pubitemid 351874419)
13. Reese AB, Ellsworth RM. The evaluation and current concept of retinoblastoma therapy. Trans Am Acad Ophthalmol Otolaryngol 1963;67:164-172.
14. Fernandez C, Repetto K, DalamonV, et al. RB1 germ-line deletions in Argentine retinoblastoma patients. Mol Diagn Ther 2007;11:55-61. (Pubitemid 46247826)
15. Antoneli CB, Ribeiro KC, Steinhorst F, et al. Treatment of retinoblastoma patients with chemoreduction plus local therapy: Experience of the AC Camargo Hospital, Brazil. J Pediatr Hematol Oncol 2006;28:342-345. (Pubitemid 43970388)
16. Abramson DH, Beaverson K, Sangani P, et al. Screening for retinoblastoma: Presenting signs as prognosticators of patient and ocular survival. Pediatrics 2003;112:1248-1255. (Pubitemid 37523403)
17. Ramirez AG, Aparicio-Ting FE, de Majors SS, et al. Interest, awareness, and perceptions of genetic testing among Hispanic family members of breast cancer survivors. Ethn Dis 2006;16:398-403. (Pubitemid 46952638)
18. Al-Obaid JA, Al-Megbel Y. Factors influencing retinoblastoma patients/siblings compliance with clinic appointments. Saudi Med J 2006;27:1561-1566. (Pubitemid 351833170)
19. Leal-Leal C, Flores-Rojo M, Medina-Sanson A, et al. A multicentre report from the Mexican Retinoblastoma Group. Br J Ophthalmol 2004;88:1074-1077. (Pubitemid 39013153)
20. Leander C, Fu LC, Pena A, et al. Impact of an education program on late diagnosis of retinoblastoma in Honduras. Pediatr Blood Cancer 2007;49:817-819. (Pubitemid 47519519)
21. Joseph B, Shanmugam MP, Srinivasan MK, et al. Retinoblastoma: Genetic testing versus conventional clinical screening in India. Mol Diagn 2004;8:237-243. (Pubitemid 40994226)
22. Blach LE, McCormick B, Abramson DH, et al. Trilateral retinoblastoma-Incidence and outcome: A decade of experience. Int J Radiat Oncol Biol Phys 1994;29:729-733. (Pubitemid 2124227)
23. Antoneli CB, Ribeiro Kde C, Sakamoto LH, et al. Trilateral retinoblastoma. Pediatr Blood Cancer 2007;48:306-310.